Bone metastasis
Conditions
Interventions
None listed
Sponsors
Tokyo Metropolitan Cancer and Infectious Diseases Center Komagome Hospital
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: 1. Patients with severe pain of NRS4 or more 2. Patients aged 20 years or over when acquiring informed consent 3. No metastatic bone tumors other than in radiation field that could cause severe pain 4. Patients with expected prognosis of 3 months or more 5. Patients with ability to assess pain, anxiety and depression by themselves 6. Patients received sufficient explanation before participating in this study, and obtained written consent by the patient himself / herself with sufficient understanding
Exclusion criteria
Exclusion criteria: 1. Patients whose RR interval cannot be accurately evaluated due to arrhythmia 2. Patients with psychiatric complications such as depression and anxiety disorders 3. Patients with apparently poor cognitive function 4. Metastatic bone tumors with fracture or strong nerve invasion (patients who are difficult to obtain the pain-relieving effect by radiation) 5. Patients with retinopathy, nephropathy or neuropathy caused by diabetes 6. Patients who are not expected to be outpatients at one month after radiation
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Correlation between autonomic nerve activity (LF/HF, HF and total power) evaluated by heart rate variability and pain assessment | — |
Countries
Japan
Contacts
Public ContactKeiko Murofushi
Tokyo Metropolitan Cancer and Infectious Diseases Center Komagome Hospital Radiation Oncology
Outcome results
None listed